The Dishman Group announces strategic alliance with Codexis

19-Feb-2010 - India

The Dishman Group announced the Formation of a strategic alliance with Codexis, Inc. a California based biotechnology company. This strategic partnership covers the use of Codexis’ proprietary enzymatic biocatalysis technology for the manufacture of building blocks, intermediates and APIs for innovator pharmaceutical companies. Dishman will be a preferred contract manufacturer for Codexis and will be able to offer the technology to its own customers. In addition, the companies will work exclusively on certain select accounts.

“We are delighted to be working with Codexis on this innovative technology. It adds another dimension to the already extensive portfolio of services offered by the Dishman Group. Our customers will benefit from cheaper, cleaner, greener processes manufactured in a low cost environment, a significant differentiator given today’s regulatory and market conditions ” said Nick Green, President Dishman CRAMS.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance